Innovation Pharmaceuticals Inc (IPIX)

[steelyeye]

Yes, this last PR leaves it uncertain, Leo could announce data lock or simply spring topline results without warning. Thanks, in either case we are very close!

"Based on information received from the data management and biostatistics vendors, study unblinding, analysis of the unblinded data and release of topline study results for the Brilacidin COVID-19 trial is anticipated to occur in mid-to-late October. The Company looks forward to the data to learn if Brilacidin’s multiple properties translate into meaningful clinical results, given the unmet need for COVID-19 therapeutics and ongoing pandemic."